The Sotrovimab arm of the "PROphylaxis for paTiEnts at risk of COVID-19 infecTion (Protect-V)" trial

Project Details

Short titleThe Sotrovimab arm of the "PROphylaxis for paTiEnts at risk of COVID-19 infecTion (Protect-V)" trial
StatusActive
Effective start/end date1/07/2215/12/25

Funding

  • Glaxosmithkline